These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3553811)

  • 21. Inhibition of phenolic glycolipid-I synthesis in extracellular Mycobacterium leprae as an indicator of antimicrobial activity.
    Harris EB; Franzblau SG; Hastings RC
    Int J Lepr Other Mycobact Dis; 1988 Dec; 56(4):588-91. PubMed ID: 3065422
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A rapid, microplate-based assay for evaluating the activity of drugs against Mycobacterium leprae, employing the reduction of Alamar Blue.
    Franzblau S
    Lepr Rev; 2000 Dec; 71 Suppl():S74-5; discussion S76. PubMed ID: 11201892
    [No Abstract]   [Full Text] [Related]  

  • 23. Double-blind evaluation of BACTEC and Buddemeyer-type radiorespirometric assays for in vitro screening of antileprosy agents.
    Franzblau SG; Biswas AN; Jenner P; Colston MJ
    Lepr Rev; 1992 Jun; 63(2):125-33. PubMed ID: 1640779
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro and in vivo activity of K-130, a dihydrofolate reductase inhibitor, against Mycobacterium leprae.
    Dhople AM
    Arzneimittelforschung; 1999 Mar; 49(3):267-71. PubMed ID: 10219472
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative in vitro activities of 20 fluoroquinolones against Mycobacterium leprae.
    Franzblau SG; White KE
    Antimicrob Agents Chemother; 1990 Feb; 34(2):229-31. PubMed ID: 2183714
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The in-vitro activities of novel benzoxazinorifamycins against Mycobacterium leprae.
    Dhople AM; Ibanez MA
    J Antimicrob Chemother; 1995 Apr; 35(4):463-71. PubMed ID: 7628981
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mycobacterium leprae: biochemical studies of clinical relevance.
    Prabhakaran K
    Indian J Lepr; 1997; 69(2):173-8. PubMed ID: 9290969
    [No Abstract]   [Full Text] [Related]  

  • 28. In vitro effects of antimicrobial agents on Mycobacterium leprae in mouse peritoneal macrophages.
    Ramasesh N; Krahenbuhl JL; Hastings RC
    Antimicrob Agents Chemother; 1989 May; 33(5):657-62. PubMed ID: 2665640
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recent studies of antileprosy drugs.
    Shepard CC; Van Landingham RM; Walker LL
    Lepr Rev; 1983 Jun; Spec No():23-30. PubMed ID: 6350771
    [No Abstract]   [Full Text] [Related]  

  • 30. Mycobacterium leprae: atypical and unclassified.
    Kato L; Kim CH
    Acta Leprol; 1979; (75):49-54. PubMed ID: 121020
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Screening of drugs for activity against Mycobacterium leprae.
    Baohong J; Matsuo Y; Colston MJ
    Int J Lepr Other Mycobact Dis; 1987 Dec; 55(4 Suppl):836-42. PubMed ID: 3325576
    [No Abstract]   [Full Text] [Related]  

  • 32. Application of ATP assay for in vitro drug screening testing against human derived M. leprae.
    Katoch VM; Katoch K; Shivannavar CT; Sharma VD; Patil MA; Bharadwaj VP
    Indian J Lepr; 1989 Jul; 61(3):333-44. PubMed ID: 2671179
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Study of antileprosy activities of some dialkyldithiocarbamate derivatives.
    Urlyapova NG; Yushchenko AA; Daudova AD; Makarov VA
    Bull Exp Biol Med; 2007 Mar; 143(3):356-8. PubMed ID: 18225763
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of drug-resistant Mycobacterium leprae using molecular methods.
    Williams DL; Gillis TP
    Indian J Lepr; 1999; 71(1):137-53. PubMed ID: 10439334
    [No Abstract]   [Full Text] [Related]  

  • 35. Screening of drug resistant strains of Mycobacterium leprae in lepromatous leprosy patients under multidrug treatment.
    Sreevatsa ; Girdhar BK; Desikan KV
    Indian J Med Res; 1988 Feb; 87():139-43. PubMed ID: 3294170
    [No Abstract]   [Full Text] [Related]  

  • 36. Report of workshop on new tools for diagnosis and epidemiology.
    Gillis TP; Cho SN
    Int J Lepr Other Mycobact Dis; 1998 Dec; 66(4):594-5. PubMed ID: 10347586
    [No Abstract]   [Full Text] [Related]  

  • 37. Investigations into the cultivation of Mycobacterium leprae. A multifactorial approach.
    Kato L
    Lepr Rev; 1986; 57 Suppl 3():209-19. PubMed ID: 3553813
    [No Abstract]   [Full Text] [Related]  

  • 38. Mouse foot pad technique for evaluation of drug resistance of M. leprae and other laboratory techniques to be used in leprosy control programmes.
    Pattyn SR
    Acta Leprol; 1983; 1(1):29-32. PubMed ID: 6401137
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of brodimoprim on Mycobacterium leprae in vitro and in mouse foot-pads.
    Dhople AM; Ortega I; Seydel JK; Gardner GD
    Indian J Lepr; 1990; 62(1):76-86. PubMed ID: 2193064
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of thalidomide on intracellular Mycobacterium leprae in normal and activated macrophages.
    Tadesse A; Shannon EJ
    Clin Diagn Lab Immunol; 2005 Jan; 12(1):130-4. PubMed ID: 15642997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.